RE:RE:RE:RE:RE:RE:RE:RE:MedX Announces Closings of First $2.5 Million of ConvertibleI think it will happen in stages, firstly you will see as a shareholder the number of locations open. You will be able to track that on their site. MedX has already announced they have an AI strategy which I hope they will give a progress report on shortly. Then we should be able to determine what the monetization component of their data and AI is worth by number of datapoints they capture from each location. Converting that data to money is the model that we don't know yet once we understand that and once they have a large volume of scans daily then we should be off to the races.
My best guess on the timeline is Q3-4. The reason I think this is of such value is MedX's image capture technology is the best in the world. It takes a perfect image on the surface of the skin as well as below the surface of the skin everytime and that is a major differentiator to any other AI system in the market using conventional image capture devices (phones). Remember 40% of images captured by iphones and sent to Dermatologists are unassessable. MedX does not have this issue. So MedX may have a huge advantage in the Datamining/AI world and that is worth a fortune to the pharmacology companies as well as a yield management tool to the dermatological community.
Thank you for your comments